A New $16,000 Postpartum Depression Drug Is Here. How Will Insurers Handle It?
April Dembosky, KQED A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health insurers have yet to publish criteria for when they will cover it, according to a new analysis of insurance policies. The lack of guidance could limit […]


